当前位置:首页 - 行情中心 - 双成药业(002693) - 财务分析

双成药业

(002693)

  

流通市值:20.05亿  总市值:20.33亿
流通股本:4.11亿   总股本:4.17亿

双成药业(002693)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.17亿元,每股收益0.00元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益57685.73万元,未分配利润-29783.83万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产86146.38万元,负债28460.65万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入182,248,825.9139,013,360.181,485,154.92274,754,114.7
营业总成本213,053,392.18150,367,222.3784,923,954.21329,188,619.07
营业利润-17,813,958.23-1,217,250.49120,989.11-9,011,507.39
利润总额-17,409,927.61-810,017.66102,529.95-8,880,963.87
净利润-17,435,104.7-835,194.75103,484.98-8,496,001.96
其他综合收益1,726.710,157.211,497.132,849.24
综合收益总额-17,433,378-825,037.54104,982.11-8,493,152.72
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计203,023,149.88252,244,470.03241,151,591.67252,394,374.44
非流动资产合计658,440,660.66650,904,991.98649,632,852.65658,624,414.64
资产总计861,463,810.54903,149,462.01890,784,444.32911,018,789.08
流动负债合计273,428,376.16301,894,883.61298,540,425.16319,361,759.55
非流动负债合计11,178,092.6510,180,330.710,487,190.4810,714,600.74
负债合计284,606,468.81312,075,214.31309,027,615.64330,076,360.29
归属于母公司股东权益合计525,277,410.41533,305,230.27518,764,494.9513,547,960.18
股东权益合计576,857,341.73591,074,247.7581,756,828.68580,942,428.79
负债和股东权益合计861,463,810.54903,149,462.01890,784,444.32911,018,789.08
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计216,678,598.23159,376,955.1180,937,116.86324,254,515.78
经营活动现金流出小计243,695,440.57179,080,487.07100,818,167.95299,036,753.76
经营活动产生的现金流量净额-27,016,842.34-19,703,531.96-19,881,051.0925,217,762.02
投资活动现金流入小计334,397,094.32264,433,468.54150,408,649.83418,869,910.25
投资活动现金流出小计279,940,627.48209,974,314.01129,422,871.29503,941,602.59
投资活动产生的现金流量净额54,456,466.8454,459,154.5320,985,778.54-85,071,692.34
筹资活动现金流入小计14,911,498.7510,497,374.624,392,70068,066,903
筹资活动现金流出小计45,419,980.568,715,001.396,372,209.7123,132,424.68
筹资活动产生的现金流量净额-30,508,481.811,782,373.23-1,979,509.7144,934,478.32
汇率变动对现金及现金等价物的影响-15,821.1122,795.92-1,680.2698,606.47
现金及现金等价物净增加额-3,084,678.4236,560,791.72-876,462.52-14,820,845.53
期末现金及现金等价物余额3,712,099.5343,357,569.675,920,315.436,796,777.95
TOP↑